Melanoma
From the Journals
COVID-19 death rate was twice as high in cancer patients in NYC study
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.
Feature
Cancer screening, monitoring down during pandemic
Use of some tests came to “a near standstill” in early April.
Feature
Home-based chemo skyrockets at one U.S. center
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
Latest News
NCCN panel: Defer nonurgent skin cancer care during pandemic
The group’s melanoma recommendations focused on deferring nonurgent care until after the pandemic passes.
From the Journals
‘Brutal’ plan to restrict palliative radiation during pandemic
New guidelines recommend giving palliative radiotherapy only in oncologic emergencies during the COVID-19 pandemic.
Feature
Advice from the front lines: How cancer centers can cope with COVID-19
The medical director of the Seattle Cancer Care Alliance offers advice for cancer centers dealing with COVID-19.
From the Journals
No staff COVID-19 diagnoses after plan at Chinese cancer center
Feature
Maintaining cancer care in the face of COVID-19
Oncologists are moving cancer patients to other hospitals, reevaluating the need for cancer treatments, and embracing telemedicine to protect...
Commentary
Perspective from the heartland: Cancer care and research during a public health crisis
Dr. Alan P. Lyss examines how the COVID-19 pandemic has and will affect cancer care and research.
Latest News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Feature
How is oncology adapting to COVID-19?